{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:40:50Z","timestamp":1792680050943,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T00:00:00Z","timestamp":1395187200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-207","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T10:20:28Z","timestamp":1395224428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia"],"prefix":"10.1186","volume":"14","author":[{"given":"Farhana","family":"Sultana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallas R","family":"English","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia ML","family":"Brotherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Drennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Heley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C David","family":"Wrede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota M","family":"Gertig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,19]]},"reference":[{"key":"4441_CR1","volume-title":"IARC Handbooks of Cancer Prevention","author":"IARC Working Group on the Evaluation of Cancer Preventive Strategies","year":"2005","unstructured":"IARC Working Group on the Evaluation of Cancer Preventive Strategies: IARC Handbooks of Cancer Prevention. 2005, Lyon: IARC Press"},{"key":"4441_CR2","volume-title":"Cervical screening in Australia 2010\u20132011","author":"The Australian Institute of Health and Welfare (AIHW)","year":"2013","unstructured":"The Australian Institute of Health and Welfare (AIHW): Cervical screening in Australia 2010\u20132011. 2013, Canberra: AIHW"},{"key":"4441_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ypmed.2007.06.007","volume":"45","author":"AR Spence","year":"2007","unstructured":"Spence AR, Goggin P, Franco EL: Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Prev Med. 2007, 45: 93-106. 10.1016\/j.ypmed.2007.06.007.","journal-title":"Prev Med"},{"key":"4441_CR4","volume-title":"Statistical Report 2011","author":"Victorian Cervical Cytology Registry","year":"2011","unstructured":"Victorian Cervical Cytology Registry: Statistical Report 2011. 2011, Carlton South, Victoria, Australia: Victorian Cytology Service Inc., http:\/\/www.vccr.org\/stats.html. (Accessed February 2, 2014)"},{"key":"4441_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1258\/jms.2009.009073","volume":"16","author":"J Waller","year":"2009","unstructured":"Waller J, Bartoszek M, Marlow L, Wardle J: Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen. 2009, 16: 199-204. 10.1258\/jms.2009.009073.","journal-title":"J Med Screen"},{"key":"4441_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1258\/0969141054855238","volume":"12","author":"K McCaffery","year":"2005","unstructured":"McCaffery K, Irwig L: Australian women\u2019s needs and preferences for information about human papillomavirus in cervical screening. J Med Screen. 2005, 12: 134-141. 10.1258\/0969141054855238.","journal-title":"J Med Screen"},{"key":"4441_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1089\/jwh.2010.2189","volume":"20","author":"S Igidbashian","year":"2011","unstructured":"Igidbashian S, Boveri S, Spolti N, Radice D, Sandri MT, Sideri M: Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities. J Wom Health. 2011, 20: 397-402. 10.1089\/jwh.2010.2189.","journal-title":"J Wom Health"},{"key":"4441_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1258\/jms.2009.009069","volume":"16","author":"A Szarewski","year":"2009","unstructured":"Szarewski A, Cadman L, Ashdown-Barr L, Waller J: Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J Med Screen. 2009, 16: 193-198. 10.1258\/jms.2009.009069.","journal-title":"J Med Screen"},{"key":"4441_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1258\/096914107780154486","volume":"14","author":"A Szarewski","year":"2007","unstructured":"Szarewski A, Cadman L, Mallett S, Austin J, Londesborough P, Waller J, Wardle J, Altman DG, Cuzick J: Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. J Med Screen. 2007, 14: 34-42. 10.1258\/096914107780154486.","journal-title":"J Med Screen"},{"key":"4441_CR10","volume-title":"Knowledge Translation: A review of Strategies to Increase Participation in Cancer Screening","author":"S Day","year":"2010","unstructured":"Day S, Dort P, Tay-Toe K: Knowledge Translation: A review of Strategies to Increase Participation in Cancer Screening. 2010, Carlton South, Victoria, Australia: Victorian Cytology Service Inc, http:\/\/www.vccr.org\/downloads\/Vol%203%20Knowledge%20Translation.pdf (Accessed February 2, 2014)"},{"key":"4441_CR11","volume-title":"Evaluation of Pilot Catch-up of Second Reminders","author":"Victorian Cervical Cytology Registry","year":"2013","unstructured":"Victorian Cervical Cytology Registry: Evaluation of Pilot Catch-up of Second Reminders. 2013, Carlton South, Victoria, Australia: Victorian Cytology Service Inc."},{"key":"4441_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Canc. 2002, 2: 342-350. 10.1038\/nrc798.","journal-title":"Nat Rev Canc"},{"key":"4441_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348: 518-527. 10.1056\/NEJMoa021641.","journal-title":"N Engl J Med"},{"key":"4441_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002, 55: 244-265. 10.1136\/jcp.55.4.244.","journal-title":"J Clin Pathol"},{"key":"4441_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/ijc.24010","volume":"124","author":"CJLM Meijer","year":"2009","unstructured":"Meijer CJLM, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DAM, Snijders PJF: Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30\u00a0years and older. Int J Canc. 2009, 124: 516-520. 10.1002\/ijc.24010.","journal-title":"Int J Canc"},{"key":"4441_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","volume":"13","author":"DC Rijkaart","year":"2012","unstructured":"Rijkaart DC, Berkhof J, Rozendaal L, van Kemenade FJ, Bulkmans NW, Heideman DA, Kenter GG, Cuzick J, Snijders PJ, Meijer CJ: Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol. 2012, 13: 78-88. 10.1016\/S1470-2045(11)70296-0.","journal-title":"Lancet Oncol"},{"key":"4441_CR17","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ijc.21955","volume":"119","author":"J Cuzick","year":"2006","unstructured":"Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T: Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Canc. 2006, 119: 1095-1101. 10.1002\/ijc.21955.","journal-title":"Int J Canc"},{"key":"4441_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/rmv.686","volume":"21","author":"CE Schmeink","year":"2011","unstructured":"Schmeink CE, Bekkers RLM, Massuger LFAG, Melchers WJG: The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening. Rev Med Virol. 2011, 21: 139-153. 10.1002\/rmv.686.","journal-title":"Rev Med Virol"},{"key":"4441_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/sti.2004.011858","volume":"81","author":"GS Ogilvie","year":"2005","unstructured":"Ogilvie GS, Patrick DM, Schulzer M, Sellors JW, Petric M, Chambers K, White R, FitzGerald JM: Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect. 2005, 81: 207-212. 10.1136\/sti.2004.011858.","journal-title":"Sex Transm Infect"},{"key":"4441_CR20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ygyno.2007.01.023","volume":"105","author":"P Petignat","year":"2007","unstructured":"Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F: Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol. 2007, 105: 530-535. 10.1016\/j.ygyno.2007.01.023.","journal-title":"Gynecol Oncol"},{"key":"4441_CR21","first-page":"817","volume":"29","author":"DE Stewart","year":"2007","unstructured":"Stewart DE, Gagliardi A, Johnston M, Howlett R, Barata P, Lewis N, Oliver T, Mai V: Self-collected samples for testing of oncogenic human papillomavirus: a systematic review. JOGC. 2007, 29: 817-828.","journal-title":"JOGC"},{"key":"4441_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/bjc.2011.236","volume":"105","author":"I Wikstrom","year":"2011","unstructured":"Wikstrom I, Lindell M, Sanner K, Wilander E: Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Canc. 2011, 105: 337-339. 10.1038\/bjc.2011.236.","journal-title":"Br J Canc"},{"key":"4441_CR23","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1158\/1055-9965.EPI-11-0307","volume":"20","author":"A Virtanen","year":"2011","unstructured":"Virtanen A, Nieminen P, Luostarinen T, Anttila A: Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Canc Epidemiol Biomarkers Prev. 2011, 20: 1960-1969. 10.1158\/1055-9965.EPI-11-0307.","journal-title":"Canc Epidemiol Biomarkers Prev"},{"key":"4441_CR24","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1002\/ijc.25581","volume":"128","author":"A Virtanen","year":"2011","unstructured":"Virtanen A, Anttila A, Luostarinen T, Nieminen P: Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Canc. 2011, 128: 2681-2687. 10.1002\/ijc.25581.","journal-title":"Int J Canc"},{"key":"4441_CR25","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/bjc.2011.48","volume":"104","author":"A Szarewski","year":"2011","unstructured":"Szarewski A, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Edwards R, Lyons D, Walker J, Christison J, Frater A, Waller J: HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Canc. 2011, 104: 915-920. 10.1038\/bjc.2011.48.","journal-title":"Br J Canc"},{"key":"4441_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/sj.bjc.6606040","volume":"104","author":"PG Rossi","year":"2011","unstructured":"Rossi PG, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, Di Pierro C, Grazzini G, Angeloni C, Capparucci P, Pekkegrini A, Schiboni ML, Sperati A, Confortini M, Bellanova C, D\u2019Addetta A, Mania E, Visioli CB, Sereno E, Carozzi F: The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Canc. 2011, 104: 248-254. 10.1038\/sj.bjc.6606040.","journal-title":"Br J Canc"},{"key":"4441_CR27","doi-asserted-by":"publisher","first-page":"c1040","DOI":"10.1136\/bmj.c1040","volume":"340","author":"M Gok","year":"2010","unstructured":"Gok M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, Voorhorst F, Belien JA, Babovic M, Snijders PJ, Meijer CJ: HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ. 2010, 340: c1040-10.1136\/bmj.c1040.","journal-title":"BMJ"},{"key":"4441_CR28","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ijc.22484","volume":"120","author":"AG Bais","year":"2007","unstructured":"Bais AG, van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voorhorst F, Babovic M, van Ballegooijen M, Helmerhorst TJ, Meijer CJ: Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Canc. 2007, 120: 1505-1510. 10.1002\/ijc.22484.","journal-title":"Int J Canc"},{"key":"4441_CR29","first-page":"2681","volume":"133","author":"H Sancho-Garnier","year":"2013","unstructured":"Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Retraite LL, Djoufelkit K, Heid P, Davies P, Piana L: HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Canc. 2013, 133: 2681-2687.","journal-title":"Int J Canc"},{"key":"4441_CR30","unstructured":"Electoral Act 2002. : , [http:\/\/www.austlii.edu.au\/cgi-bin\/download.cgi\/cgi-bin\/download.cgi\/download\/au\/legis\/vic\/consol_act\/ea2002103.pdf],"},{"key":"4441_CR31","volume-title":"Cervical screening in Australia 2010\u20132011","author":"Welfare AIoHa","year":"2013","unstructured":"Welfare AIoHa: Cervical screening in Australia 2010\u20132011. 2013, Canberra: Australian Institute of Health and Welfare"},{"key":"4441_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/oxfordjournals.jncimonographs.a003488","volume":"31","author":"EL Franco","year":"2003","unstructured":"Franco EL: Chapter 13: primary screening of cervical cancer with human papillomavirus tests. J Natl Canc Inst Monogr. 2003, 31: 89-96.","journal-title":"J Natl Canc Inst Monogr"},{"key":"4441_CR33","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/dji187","volume":"97","author":"MJ Khan","year":"2005","unstructured":"Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M: The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Canc Inst. 2005, 97: 1072-1079. 10.1093\/jnci\/dji187.","journal-title":"J Natl Canc Inst"},{"key":"4441_CR34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","volume":"135","author":"MH Stoler","year":"2011","unstructured":"Stoler MH, Wright TC, Sharma A, Apple R, Gutekunst K, Wright TL: High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol. 2011, 135: 468-475. 10.1309\/AJCPZ5JY6FCVNMOT.","journal-title":"Am J Clin Pathol"},{"key":"4441_CR35","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1128\/JCM.00337-12","volume":"50","author":"Y Park","year":"2012","unstructured":"Park Y, Lee E, Choi J, Jeong S, Kim HS: Comparison of the Abbott realtime high-risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid capture 2 assays to direct sequencing and genotyping of HPV DNA. J Clin Microbiol. 2012, 50: 2359-2365. 10.1128\/JCM.00337-12.","journal-title":"J Clin Microbiol"},{"key":"4441_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jmoldx.2011.09.005","volume":"14","author":"ML Lindemann","year":"2012","unstructured":"Lindemann ML, Dominguez MJ, de Antonio JC, Sandri MT, Tricca A, Sideri M, Khiri H, Ravet S, Boyle S, Aldrich C, Halfon P: Analytical comparison of the cobas HPV test with Hybrid capture 2 for the detection of high-risk HPV genotypes. J Mol Diagn. 2012, 14: 65-70. 10.1016\/j.jmoldx.2011.09.005.","journal-title":"J Mol Diagn"},{"key":"4441_CR37","volume-title":"Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities","author":"National Health and Medical Research Council","year":"2005","unstructured":"National Health and Medical Research Council: Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities. 2005, Canberra, Australia: Australian Government"},{"key":"4441_CR38","unstructured":"National cervical screening program renewal. [http:\/\/www.cancerscreening.gov.au\/internet\/screening\/publishing.nsf\/Content\/ncsp-renewal],"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-207\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:31:50Z","timestamp":1630553510000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,19]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4441"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-207","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,19]]},"assertion":[{"value":"17 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"207"}}